UPDATE: BMO Capital Starts Rapt Therapeutics (RAPT) at Outperform, 'Altering Immune Response Through CCR4'
Tweet Send to a Friend
(Updated - November 25, 2019 5:06 AM EST)
(update comment)BMO Capital analyst Do Kim initiates coverage on Rapt Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
(update comment)BMO Capital analyst Do Kim initiates coverage on Rapt Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
